Literature DB >> 30640460

Applications of Deuterium in Medicinal Chemistry.

Tracey Pirali1, Marta Serafini1, Sarah Cargnin1, Armando A Genazzani1.   

Abstract

The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions, and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of coadministered boosters, and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing, and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This Perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30640460     DOI: 10.1021/acs.jmedchem.8b01808

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  58 in total

1.  Catalytic Deuterium Incorporation within Metabolically Stable β-Amino C-H Bonds of Drug Molecules.

Authors:  Yejin Chang; Ahmet Yesilcimen; Min Cao; Yuyang Zhang; Bochao Zhang; Jessica Z Chan; Masayuki Wasa
Journal:  J Am Chem Soc       Date:  2019-09-09       Impact factor: 15.419

2.  From methylene bridged diindole to carbonyl linked benzimidazoleindole: Development of potent and metabolically stable PCSK9 modulators.

Authors:  Haibo Xie; Ka Yang; Gabrielle N Winston-McPherson; Donnie S Stapleton; Mark P Keller; Alan D Attie; Kerry A Smith; Weiping Tang
Journal:  Eur J Med Chem       Date:  2020-08-04       Impact factor: 6.514

3.  Enhancement of a Heroin Vaccine through Hapten Deuteration.

Authors:  Tyson F Belz; Paul T Bremer; Bin Zhou; Beverly Ellis; Lisa M Eubanks; Kim D Janda
Journal:  J Am Chem Soc       Date:  2020-07-27       Impact factor: 15.419

4.  B(C6F5)3-Catalyzed α-Deuteration of Bioactive Carbonyl Compounds with D2O.

Authors:  Yejin Chang; Tanner Myers; Masayuki Wasa
Journal:  Adv Synth Catal       Date:  2019-11-26       Impact factor: 5.837

5.  Visible-Light-Enabled Direct Decarboxylative N-Alkylation.

Authors:  Vu T Nguyen; Viet D Nguyen; Graham C Haug; Ngan T H Vuong; Hang T Dang; Hadi D Arman; Oleg V Larionov
Journal:  Angew Chem Int Ed Engl       Date:  2020-03-17       Impact factor: 15.336

6.  Deuteration of the farnesyl terminal methyl groups of δ-tocotrienol and its effects on the metabolic stability and ability of inducing G-CSF production.

Authors:  Xingui Liu; Zhengya Gao; Qiang Fu; Lin Song; Peiyi Zhang; Xuan Zhang; Howard Hendrickson; Peter A Crooks; Daohong Zhou; Guangrong Zheng
Journal:  Bioorg Med Chem       Date:  2020-04-08       Impact factor: 3.641

7.  Deuteration of Formyl Groups via a Catalytic Radical H/D Exchange Approach.

Authors:  Yueteng Zhang; Peng Ji; Yue Dong; Yongyi Wei; Wei Wang
Journal:  ACS Catal       Date:  2020-01-23       Impact factor: 13.084

8.  Late-Stage Conversion of a Metabolically Labile Aryl Methyl Ether-Containing Natural Product to Fluoroalkyl Analogues.

Authors:  Jacob P Sorrentino; Brett R Ambler; Ryan A Altman
Journal:  J Org Chem       Date:  2020-03-27       Impact factor: 4.354

9.  Synthesis of Enantioenriched α-Deuterated α-Amino Acids Enabled by an Organophotocatalytic Radical Approach.

Authors:  Peng Ji; Yueteng Zhang; Yue Dong; He Huang; Yongyi Wei; Wei Wang
Journal:  Org Lett       Date:  2020-02-11       Impact factor: 6.005

10.  [11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates.

Authors:  Laura Kuebler; Sabrina Buss; Andrei Leonov; Sergey Ryazanov; Felix Schmidt; Andreas Maurer; Daniel Weckbecker; Anne M Landau; Thea P Lillethorup; Daniel Bleher; Ran Sing Saw; Bernd J Pichler; Christian Griesinger; Armin Giese; Kristina Herfert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.